Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 19, 2016CancerOpen Access

Chemotherapy for soft tissue sarcoma

View Full Paper
Ask AI
Bookmark
Share

Authors

RRRavin RatanSPShreyaskumar Patel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ratan et al. (2016) studied this question.

synapsesocial.com/papers/69dd5cc0629747396240c41chttps://doi.org/10.1002/cncr.30191
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.1997 · 258 citations
  2. 2A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas1983 · 359 citations
  3. 3A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma2008 · 995 citations
  4. 4Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.1987 · 301 citations
  5. 5Results of Two Consecutive Trials of Dose-Intensive Chemotherapy With Doxorubicin and Ifosfamide in Patients With Sarcomas1998 · 200 citations